News

A diagnostic tool that can differentiate between healthy and cancerous tissue, called the MasSpec Pen, has been tested for the first time in surgery.

About one-third of children diagnosed with severe malaria may instead have an alternative cause of illness, but simple blood tests could help researchers distinguish between the two and speed up research on new treatments.

Researchers have revealed a possible genetic pathway behind the neurological dysfunction of Rett syndrome. Deficiencies in key genes trigger neural stem cells to generate less neurons by producing more astrocytes.

Researchers lead call to actively diversify the genomic resources used to advance immunogenomics more equitably.

The epigenetic modifications in tumor-infiltrating CD4 T-cells influenced by Glioblastoma (GBM) may be responsible for the immunosuppressed state seen in GBM patients.

In an article appearing in Nature Biomedical Engineering, a team of scientists report real-world results on SwabSeq, a high-throughput testing platform that uses sequencing to test thousands of samples at a time to detect SARS-CoV-2.

An Oxford-led team, working with Cambridge and international scholars, has discovered hundreds of genetic markers driving two of life's most momentous milestones - the age at which people first have sex and become parents.

Six antibody characteristics could help scientists identify which pregnant women are at risk of placental malaria infections.

A new COVID-19 test can analyze a large number of swabs simultaneously and has similarly high sensitivity as the common qPCR test.

A University of Houston biomedical researcher reports a step forward in diagnosing intestinal diseases, including colorectal cancer, ulcerative colitis and Crohn's disease using stool proteins. The ultimate goal of this new research is to replace the invasive endoscopy test by finding stool markers that can predict what is happening in the intestine without having to do endoscopy.